Arcadia Biosciences (NASDAQ:RKDA) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDAFree Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Price Performance

Shares of RKDA opened at $5.01 on Friday. Arcadia Biosciences has a 12 month low of $1.85 and a 12 month high of $10.31. The stock has a fifty day moving average price of $4.81 and a 200 day moving average price of $3.70. The company has a market cap of $6.84 million, a P/E ratio of -1.17 and a beta of 0.90.

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.

Recommended Stories

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.